Middle East & Africa Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market Size & Outlook
Related Markets
MEA cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market highlights
- The MEA cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market generated a revenue of USD 316.6 million in 2024.
- The market is expected to grow at a CAGR of 4.3% from 2025 to 2035.
- In terms of segment, cervical cancer screening was the largest revenue generating type in 2024.
- Cervical Cancer Screening is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2035.
MEA data book summary
| Market revenue in 2024 | USD 316.6 million |
| Market revenue in 2035 | USD 500.0 million |
| Growth rate | 4.3% (CAGR from 2025 to 2035) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.8% of the global cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2035.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,288.6 million by 2035.
Cervical cancer screening was the largest segment with a revenue share of 50.54% in 2024. Horizon Databook has segmented the Middle East & Africa cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market based on cervical cancer screening, cervical cancer diagnostics, pre-cancerous lesion treatment covering the revenue growth of each sub-segment from 2018 to 2035.
The Middle East & Africa region, including South Africa, Saudi Arabia, and the UAE, is experiencing growth in the cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market due to the high prevalence of the disease.
In the Middle East and North Africa region, cervical cancer remains a leading cause of female mortality. According to the ICO/IARC HPV Information Centre (2023), deaths are projected to rise from 8,964 in 2012 to 16,241 by 2030, averaging 44 fatalities per day without intervention.
HPV vaccination, particularly for girls aged 9–13, offers up to 99% efficacy with minimal side effects. However, the financial burden of treating advanced cervical cancer remains a significant challenge for many families, underscoring the need for increased preventive measures and accessible healthcare solutions.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Scope
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MedGyn Products | View profile | 51-100 | Addison, Illinois, United States, North America | https://www.medgyn.com |
| Utah Medical Products Inc | View profile | 190 | 7043 South 300 West, Midvale, UT, United States, 84047 | http://www.utahmed.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
MEA cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market size, by country, 2018-2035 (US$M)
Middle East & Africa Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Outlook Share, 2024 & 2035 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
